SWISSCANTO PRIVATE EQUITY
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
SWISSCANTO PRIVATE EQUITY
Industry:
Financial Services Funding Platform
Founded:
2018-01-01
Status:
Active
Contact:
+41 58 344 49 00
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Global Site Tag Amazon US Privacy User Signal Mechanism
Similar Organizations
Dreamit Health
Dreamit Health is an accelerator investor which concentrates on health it, and medical device startups.
Winton Ventures
Winton Ventures invests in companies operating in the cybersecurity; energy and environment; and data science-driven healthcare sectors.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-16 | Memo Therapeutics | Swisscanto Private Equity investment in Series B - Memo Therapeutics | 23 M CHF |
| 2022-01-19 | Fotokite | Swisscanto Private Equity investment in Series B - Fotokite | 13.7 M CHF |
| 2021-06-22 | Sulzer Schmid | Swisscanto Private Equity investment in Series B - Sulzer Schmid | N/A |
| 2021-05-12 | MedTrace Pharma | Swisscanto Private Equity investment in Venture Round - MedTrace Pharma | 180 M DKK |
| 2021-01-20 | 1plusX, a TripleLift company | Swisscanto Private Equity investment in Series B - 1plusX, a TripleLift company | 7.8 M USD |
| 2020-11-06 | Memo Therapeutics | Swisscanto Private Equity investment in Series B - Memo Therapeutics | 14 M CHF |
| 2020-08-12 | Varjo | Swisscanto Private Equity investment in Series C - Varjo | 54 M USD |
| 2020-07-10 | Beekeeper | Swisscanto Private Equity investment in Series B - Beekeeper | 10 M USD |
| 2020-02-14 | OncoDNA | Swisscanto Private Equity investment in Series B - OncoDNA | 19 M EUR |
| 2019-09-18 | Versantis | Swisscanto Private Equity investment in Series B - Versantis | 16 M CHF |